Effect of anti-CD52 antibody alemtuzumab on ex-vivo culture of umbilical cord blood stem cells

BACKGROUND: Excessive maturation of hematopoietic cells leads to a reduction of long-term proliferative capability during cord blood (CB) expansion. In this study, we report the effects of anit-CD52 (Alemtuzumab, Campath) on both short- and long-term ex vivo expansion of CB hematopoietic stem cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Che K, Sun, Li, Feng, Qi, Law, Ping, Chua, Wei T, Lim, Shy N, Hwang, William YK
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582233/
https://www.ncbi.nlm.nih.gov/pubmed/18947412
http://dx.doi.org/10.1186/1756-8722-1-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582233/
https://www.ncbi.nlm.nih.gov/pubmed/18947412
http://dx.doi.org/10.1186/1756-8722-1-19

Ejemplares similares